Collegium Pharmaceutical (NASDAQ:COLL) reported its Q4 earnings results on Thursday, February 22, 2024 at 04:10 PM.

Here's what investors need to know about the announcement.

Earnings

Collegium Pharmaceutical beat estimated earnings by 139.39%, reporting an EPS of $1.58 versus an estimate of $0.66.

Revenue was up $20.12 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.82 which was followed by a 6.6% increase in the share price the next day.

Here's a look at Collegium Pharmaceutical's past performance:

To track all earnings releases for Collegium Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.